BOD Insider Trading

Insider Ownership Percentage: 42.64%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Bod Science Insider Trading History Chart

This chart shows the insider buying and selling history at Bod Science by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bod Science Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/14/2022 12:03 PM ET

This chart shows the closing price history over time for BOD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Bod Science Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/6/2023David BakerInsiderIssued937,500A$0.07A$64,687.50
8/23/2023Joanne (Jo) PattersonInsiderCancelled361,179A$0.08A$28,894.32
3/9/2023David BakerInsiderBuy118,506A$0.06A$7,584.38
3/7/2023David BakerInsiderBuy273,524A$0.06A$16,411.44
12/19/2022George LiveryInsiderExpiry500,000A$0.15A$75,000.00
12/5/2022David BakerInsiderIssued1,250,000A$0.08A$100,000.00
10/13/2022David BakerInsiderIssued1,485,295A$0.08A$118,823.60
10/6/2022George LiveryInsiderIssued70,589A$0.08A$5,647.12
See Full Table

SEC Filings (Institutional Ownership Changes) for Bod Science (ASX:BOD)

5.87% of Bod Science stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products for medical markets. The company provides Flexofytol, an anti-inflammatory derived from a scientifically validated and clinically trialed turmeric extract that helps in improving joint pain and stiffness, joint health, limiting the ageing of cartilage, and reducing inflammation caused by mild arthritis; and Sedistress, a passion flower extract that reduces the symptoms of stress, anxiety, and insomnia, as well as contract manufacturing services. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Double Bay, Australia.
Read More on Bod Science

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Bod Science?

Bod Science's top insider investors include:
  1. David Baker (Insider)
  2. George Livery (Insider)
  3. Joanne (Jo) Patterson (Insider)
Learn More about top insider investors at Bod Science.